NovaBay Pharmaceuticals, Inc. is engaged in wound care products. The Company manufactures and sells its proprietary form of hypochlorous acid for the wound care market through its NeutroPhase and PhaseOne branded products. NeutroPhase and PhaseOne are used for cleansing and irrigation as part of surgical procedures, as well as treating wounds, burns, ulcers and other injuries.

Stablecoin Development Ord Shs プロフィール



企業コード- -

会社名- -

上場日- -

最高経営責任者「CEO」- -

従業員数- -

証券種類- -

決算期末- -

本社所在地- -

都市- -

証券取引所- -

国- -

郵便番号- -

電話番号- -

ウェブサイト- -

企業コード- -

上場日- -

最高経営責任者「CEO」- -

Stablecoin Development Ord Shsの経営陣



会社名

会社名/ポジション

ポジション

株式保有

変動額

Ms. Swan Sit

Independent Director

172.00

Mr. Paul E. Freiman, Ph.D.

Independent Director

Mr. Justin M. Hall, Esq.

Vice President - Business Development, General Counsel, Corporate Secretary

Dr. Yenyou (Jeff) Zheng, Ph.D.

Independent Director

Mr. Tommy Law

Chief Financial Officer, Treasurer

-100.00%

Capt. Jody Cain

IR Contact Officer

Mr. Michael Kazley

Chairman of the Board, Chief Executive Officer

Mr. Henry Blynn

Chief Operating Officer

Mr. David Garcia Rios

Independent Director

会社名

会社名/ポジション

ポジション

株式保有

変動額

Ms. Swan Sit

Independent Director

172.00

Mr. Paul E. Freiman, Ph.D.

Independent Director

Mr. Justin M. Hall, Esq.

Vice President - Business Development, General Counsel, Corporate Secretary

Dr. Yenyou (Jeff) Zheng, Ph.D.

Independent Director

Mr. Tommy Law

Chief Financial Officer, Treasurer

-100.00%

Capt. Jody Cain

IR Contact Officer

よくある質問

Stablecoin Development Ord Shsの上位5名の株主は誰ですか？



Stablecoin Development Ord Shsの上位5名の株主は以下のとおりです。Ms. Swan Sit

Stablecoin Development Ord Shs（SDEV）の株式を保有している機関の数はいくつですか？



2026Q2時点で、Stablecoin Development Ord Shsの株式を保有している機関は41社あり、保有株式の総市場価値は約1.42Mで、全体の5.34%を占めています。2026Q1と比較して、機関の持ち株は1112322.00増加しています。